Our top pick for
Titan Medical Inc is a medical devices business based in the US. Titan Medical shares (TMDI) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$1.50|
|52-week range||$0.65 - $3.47|
|50-day moving average||$1.56|
|200-day moving average||$1.66|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.43|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-11)||2.04%|
|1 month (2021-09-17)||-8.54%|
|3 months (2021-07-19)||-6.25%|
|6 months (2021-04-19)||-6.25%|
|1 year (2020-10-16)||94.81%|
|2 years (2019-10-18)||182.70%|
|3 years (2018-10-18)||2.07|
|5 years (2016-10-18)||268.91%|
Valuing Titan Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Titan Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Titan Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.3 million.
The EBITDA is a measure of a Titan Medical's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$20.1 million|
|Gross profit TTM||$20 million|
|Return on assets TTM||-20.4%|
|Return on equity TTM||-221.57%|
|Market capitalisation||$167.6 million|
TTM: trailing 12 months
There are currently 1.6 million Titan Medical shares held short by investors – that's known as Titan Medical's "short interest". This figure is 26.6% down from 2.2 million last month.
There are a few different ways that this level of interest in shorting Titan Medical shares can be evaluated.
Titan Medical's "short interest ratio" (SIR) is the quantity of Titan Medical shares currently shorted divided by the average quantity of Titan Medical shares traded daily (recently around 301963.05147059). Titan Medical's SIR currently stands at 5.44. In other words for every 100,000 Titan Medical shares traded daily on the market, roughly 5440 shares are currently held short.
However Titan Medical's short interest can also be evaluated against the total number of Titan Medical shares, or, against the total number of tradable Titan Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Titan Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Titan Medical shares in existence, roughly 10 shares are currently held short) or 0.0148% of the tradable shares (for every 100,000 tradable Titan Medical shares, roughly 15 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Titan Medical.
Find out more about how you can short Titan Medical stock.
We're not expecting Titan Medical to pay a dividend over the next 12 months.
Titan Medical's shares were split on a 1:30 basis on 18 June 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Titan Medical shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Titan Medical shares which in turn could have impacted Titan Medical's share price.
Over the last 12 months, Titan Medical's shares have ranged in value from as little as $0.6539 up to $3.4661. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Titan Medical's is 4.6511. This would suggest that Titan Medical's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Titan Medical Inc. , a research and development stage company, focuses on the design, development, and commercialization of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS). The company is developing the Enos robotic single-access surgical system (Enos system), a single-port robotic surgical system that includes a surgeon-controlled patient cart that includes a 3D high definition vision system and multi-articulating instruments for performing MIS procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. The Enos system enables surgeons to perform surgical procedures for gynecologic, urologic, colorectal, and bariatric. Titan Medical Inc. is headquartered in Toronto, Canada. .
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.